Literature DB >> 23971762

Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.

William B Feldman1, Aaron J Clark, Michael Safaee, Christopher P Ames, Andrew T Parsa.   

Abstract

OBJECT: Myxopapillary ependymomas (MPEs) are rare WHO Grade I tumors found in the conus medullaris, cauda equina, and filum terminale. Treatment generally consists of resection with or without adjuvant radiotherapy. Evidence-based guidelines for surgical management are lacking due to the rarity of this tumor.
METHODS: An English-language PubMed search was performed using the key words "myxopapillary" and "ependymoma." Reports describing fewer than 3 patients or those lacking data on the extent of resection or radiotherapy were excluded. A total of 28 articles describing 475 patients met the authors' inclusion criteria. Patients were grouped by extent of resection and whether or not they underwent adjuvant radiotherapy. Differences in recurrence rates were assessed by chi-square test.
RESULTS: The overall recurrence rate was 15.5% in patients treated by gross-total resection (GTR) and 32.6% in patients treated by subtotal resection (STR), irrespective of whether they underwent adjuvant therapy (p < 0.001). Regardless of the extent of resection, adjuvant radiotherapy was not associated with a decrease in recurrence rates. The overall recurrence rate was 15.6% in patients who underwent GTR and radiotherapy compared with 15.9% in patients who underwent GTR alone (p = 0.58), and it was 29.3% in patients who underwent STR and radiotherapy compared with 35.1% in those who underwent STR alone (p = 0.53). The difference between recurrence rates for patients who underwent GTR alone versus STR and radiotherapy was statistically significant (p = 0.02). Subgroup analysis demonstrated significantly higher recurrence rates in pediatric patients compared with adults (40.5% vs 23.4%, respectively; p = 0.02). Even in the setting of GTR alone, recurrence rates were higher in pediatric patients (65% vs 7.6%; p < 0.001).
CONCLUSIONS: Gross-total resection alone is associated with decreased recurrence rates compared with STR with or without radiotherapy. The authors' results suggest that treatment goals should include attempted GTR whenever possible. The observation that children benefitted from radiation therapy to a greater extent than did adults suggests that biological differences between tumors in these patient populations warrants more rigorous scientific studies.

Entities:  

Mesh:

Year:  2013        PMID: 23971762     DOI: 10.3171/2013.6.SPINE12927

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  25 in total

1.  National trends in management of adult myxopapillary ependymomas.

Authors:  Daphne B Scarpelli; Claire B Turina; Patrick D Kelly; Arpine Khudanyan; Jerry J Jaboin; Shearwood McClelland
Journal:  J Clin Neurosci       Date:  2020-01-24       Impact factor: 1.961

Review 2.  Enhanced recovery after surgery in intramedullary and extramedullary spinal cord lesions: perioperative considerations and recommendations.

Authors:  Sauson Soldozy; Parantap Patel; Mazin Elsarrag; Pedro Norat; Daniel M Raper; Jennifer D Sokolowski; Kaan Yağmurlu; Min S Park; Petr Tvrdik; M Yashar S Kalani
Journal:  Spinal Cord       Date:  2019-07-29       Impact factor: 2.772

3.  Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Authors:  Elizabeth Vera-Bolanos; Kenneth Aldape; Ying Yuan; Jimin Wu; Khalida Wani; Mary Jo Necesito-Reyes; Howard Colman; Girish Dhall; Frank S Lieberman; Philippe Metellus; Tom Mikkelsen; Antonio Omuro; Sonia Partap; Michael Prados; H Ian Robins; Riccardo Soffietti; Jing Wu; Mark R Gilbert; Terri S Armstrong
Journal:  Neuro Oncol       Date:  2014-08-13       Impact factor: 12.300

Review 4.  Updates in the management of intradural spinal cord tumors: a radiation oncology focus.

Authors:  Rupesh Kotecha; Minesh P Mehta; Eric L Chang; Paul D Brown; John H Suh; Simon S Lo; Sunit Das; Haider H Samawi; Julia Keith; James Perry; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2019-06-10       Impact factor: 12.300

5.  Myxopapillary ependymomas in children: imaging, treatment and outcomes.

Authors:  Pratiti Bandopadhayay; V Michelle Silvera; Pedro D S C Ciarlini; Hayley Malkin; Wenya Linda Bi; Guillaume Bergthold; Ahmed M Faisal; Nicole J Ullrich; Karen Marcus; R Michael Scott; Rameen Beroukhim; Peter E Manley; Susan N Chi; Keith L Ligon; Liliana C Goumnerova; Mark W Kieran
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

Review 6.  Treatment patterns of children with spine and spinal cord tumors: national outcomes and review of the literature.

Authors:  Faris Shweikeh; Carolyn Quinsey; Roger Murayi; Ryan Randle; Miriam Nuño; Mark D Krieger; J Patrick Johnson
Journal:  Childs Nerv Syst       Date:  2017-05-08       Impact factor: 1.475

7.  Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.

Authors:  James E Bates; Gyujae Choi; Michael T Milano
Journal:  J Neurooncol       Date:  2016-06-15       Impact factor: 4.130

8.  Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database.

Authors:  Kelly M Lucchesi; Ryan Grant; Kristopher T Kahle; Asher M Marks; Michael L DiLuna
Journal:  J Neurooncol       Date:  2016-07-16       Impact factor: 4.130

9.  Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients.

Authors:  Anne-Sophie Montero; Suzanne Tran; Aymeric Amelot; Félix Berriat; Guillaume Lot; Stephan Gaillard; Chiara Villa; Marc Polivka; Clovis Adam; Ahmed Idbaih; Loïc Feuvret; Alexandre Carpentier; Fabrice Parker; Franck Bielle; Bertrand Mathon
Journal:  J Neurooncol       Date:  2021-02-23       Impact factor: 4.130

10.  Complete Versus Incomplete Surgical Resection in Intramedullary Ependymomas: A Systematic Review and Meta-analysis.

Authors:  Farhad Salari; Mehdi Golpayegani; Mohsen Sadeghi-Naini; Sara Hanaei; Farhad Shokraneh; Ayat Ahmadi; Hamid Reza Khayat-Kashani; Alexander R Vacarro; Vafa Rahimi-Movaghar
Journal:  Global Spine J       Date:  2020-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.